Clarivate

MAY 14, 2024

The company filed for marketing approval of their semaglutide biosimilar for the treatment of T2D with the National Medical Products Administration (NMPA) in April 2024, and this is expected to amplify clinical development of semaglutide biosimilars from domestic manufacturers in the next two to three years.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Medico Reach

APRIL 21, 2022

Are you a healthcare marketer looking to promote your products? And in this competitive digital era, email marketing is still one of the best strategies to boost your sales. Healthcare email marketing allows you to reach out to your target audience and develop a relationship with them. Helps Set Your Brand Apart.

Marketing 52

Marketing Healthcare Healthcare Sales 52

Healthcare Success

APRIL 8, 2024

As an engineering undergrad, I took a Marketing 101 class on a lark, seeking to better understand the psychology behind consumer behavior and developing products with a competitive edge. The 7 tactics of marketing can help you: Develop a competitive advantage. My favorite example of packing in healthcare is “The Mommy Makeover.”

Marketing 112

Marketing Competition Patients Healthcare 112

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. They do not have biosimilar or generic competition available in the market.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Clarify Health

JANUARY 16, 2024

Employers are struggling under the weight of increasing healthcare costs for their employees — and are turning to third-party administrators to help. in 2024, according to a report from Mercer — and that projection includes changes employers plan to make to hold down costs.

Networking 52

Networking Healthcare Healthcare Insurance 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

PM360

DECEMBER 20, 2023

listed on the stock exchanges, is up 13%, according to Leerink Partners’ “Navigating the Complex Terrain: Healthcare and Biotech Markets in Q3 2023” report. Learn more about why each company went with its respective strategy and the current outlook for each company in 2024 and beyond. The deal is expected to close in 2024.

Management 109

Management Marketing Healthcare Healthcare 109

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Legacy MEDSearch

MARCH 7, 2024

Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. The company aims to offer the device at a competitive price point, but further pricing details will be shared closer to the product’s release date.

Food and Drug Administration 52

Food and Drug Administration FDA Food Management 52

Star OUTiCO

DECEMBER 11, 2023

I started out in non-industry specific high street recruitment where I cut my teeth and then moved on to specialising in pharmaceutical recruitment and healthcare comes. Going forward into 2024 there are some exciting things which I’m keen to get stuck into. Candidates really need to set themselves apart from their competition.

Recruitment 52

Recruitment Consulting Competition Specialization 52

PM360

APRIL 22, 2024

In the rapidly evolving landscape of healthcare, where breakthrough therapies and treatments emerge at an unprecedented pace, conventional boundaries are rapidly shifting. It covers the product lifecycle in its entirety by delivering innovative approaches to anticipate and address the needs of patients, healthcare providers, and payers alike.

Medical 52

Medical Healthcare Healthcare Education 52

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. A top physician request that we see is to provide an illustration of how their opinions and actions affect broad healthcare outcomes.

Education 59

Education Physicians Healthcare Healthcare 59

PM360

MARCH 22, 2024

Without the imperative of immediate commercial outcomes, Field Medical Affairs also exists as a trusted relationship-builder in which medical science liaisons (MSLs) and healthcare providers (HCPs) can discuss treatment possibilities and scientific concerns candidly. Reference: The Future of HCP Engagement Impact. EPG Health. October 2023.

Medical 52

Medical Education Medical science Sales 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? We asked our team to share their insights on healthcare innovation, new regulations, and trends we expect to impact your business this year. We know a few!

Healthcare 52

Healthcare Healthcare Management Insurance 52

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said. In 2024, ARPA removes the 100% AMP cap.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

NOVEMBER 17, 2022

Leela Barham argues that more transparency at a minimum is required next time around, should a VPAS style of agreement be agreed upon for 2024 onwards, and perhaps even a more radical re-think about how a deal is struck in the future. Predictable for government. Being forewarned is being forearmed after all. The other company is not named.

Government 96

Government Sales Medicine Consulting 96

Medico Reach

FEBRUARY 8, 2023

billion during 2020-2024. Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion in 2020 and will project growth of USD 4.18

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

NOVEMBER 13, 2023

Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. That’s rare in healthcare, and we believe it likely improves communication and joint decision making along their health journey together.

Media 52

Media Prescription Healthcare Provider Patients 52

Clarify Health

FEBRUARY 6, 2024

That way, they can continue to grow membership and thrive against the competition. Price and Data Transparency CMS finalized the Transparency in Coverage Rule in 2020 as a way to empower healthcare consumers to make informed decisions about their health. These changes are designed to make care easier to access for enrollees.

Networking 52

Networking Insurance Government Management 52

Clarify Health

DECEMBER 5, 2023

hospitals must share clear, accessible information online about the standard charges for the services provided to improve healthcare price transparency. They will help strengthen efforts to access and analyze this valuable healthcare price data for patients and other stakeholders. Since January 2021, U.S.

Healthcare 52

Healthcare Healthcare Competition Insurance 52

PM360

FEBRUARY 1, 2024

As we step into 2024, these insights pave the way for understanding the industry’s trajectory in the near future. This confidence, coupled with strategic planning and collaborative efforts, stands poised to drive the biotech sector towards ground breaking innovations that could redefine the future of healthcare.

Recruitment 52

Recruitment Healthcare Healthcare Management 52

PM360

SEPTEMBER 28, 2022

healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. How drug manufacturers should prepare for 2024: Have a strategy for request-for-proposal (RFP) season: RFPs for plan year 2024 will come out in late 2022 and run into early 2023. The IRA affects several components of the U.S.

Government 97

Government Manufacturing Prescription Competition 97

Pharmaceutical Technology

SEPTEMBER 26, 2022

Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. stake in their consumer healthcare joint venture for $13bn.

Competition 64

Competition Manufacturing Marketing Distribution 64

European Pharmaceutical Review

FEBRUARY 7, 2023

Some of the current and anticipated proposals will not be adopted in 2023, or even before the end of tenure of the current European Commission in late 2024. However, a delicate balance will need to be struck between the need for affordable and accessible medicinal products and the desire to foster innovation and competitiveness in the EU.

Government 92

Government Medical Medicine Marketing 92

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. A prime example of strategic spending is Merck & Co./MSD, MSD, which continued its spending spree to strengthen its oncology portfolio.

Pharma 59

Pharma Biopharma Prospecting Competition 59

pharmaphorum

JANUARY 4, 2023

providing personalised healthcare consisting in assessing, maintaining, or restoring the state of health of individuals. It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10. When will it come into force?

Pharmaceutical 89

Pharmaceutical Electronics Healthcare Healthcare 89

PM360

DECEMBER 20, 2023

A significant battle for the hearts and minds of healthcare professionals (HCPs) will play out in social media during 2024. Fearless Forums The competition among online private social physician communities—the so-called “Walled Gardens” —is intense.

Media 122

Media Physicians Pharma reps Pharma Rep 122

Evolve Your Success

APRIL 11, 2023

There’s less patient pain and ultimately less cost for the healthcare facility. We had some great responses because it solves some problems on the clinician side, the patient side and the healthcare provider side. That eliminates the need for the patient to have to go back to the healthcare facility. It is crowded.

Sales 52

Sales Medical Medical sales Media 52

Evolve Your Success

JANUARY 10, 2024

One thing that is not talked about enough, and I’m going to have some guests on here in 2024, is that there are a lot of people who get into this space and then quit 5 or 6 months in. If you’re not very proactive in your career, it’s too competitive. It’s double-sided. He doesn’t do it every week.”

Sales 52

Sales Medical Medical sales Doctors 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Heidi Hunter, biotech board director and former President of specialty solutions at Cardinal Health, says that the payer is in charge in the US healthcare system.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

APRIL 4, 2023

million) in the latest extension round, which was led by Pontifax Venture Capital, and existing investors Novo Holdings and Ysios Capital, along with RA Capital Management, HealthCap and Gilde Healthcare. Adcendo then went on to raise the additional €31 million ($33.9 GlobalData is the parent company of Pharmaceutical Technology.

Prospecting 52

Prospecting Competition Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 25, 2023

Morgan Healthcare Conference in San Francisco, which finished on January 12. The IPO landscape seen in 2020 and 2021 should be viewed as a distortion rather than a norm, says Sameer Khambadkone, partner at ICR Westwicke, adding that this will likely not come back in 2024. But such areas are highly competitive.

Marketing 69

Marketing Biopharma Pharma Competition 69

Pharmaceutical Technology

DECEMBER 19, 2022

by the end of 2023 and may continue to rise in 2024 to 5%. Getting funding is going to be more difficult,” says Kyle Faget, partner and co-chair of Foley & Lardner’s Healthcare and Life Sciences Practices, Boston, Massachusetts. JP Morgan predicts that the US unemployment rate could rise to 4.3%

Pharmaceutical 69

Pharmaceutical Manufacturing Government Medicine 69

Pharmaceutical Technology

JUNE 15, 2023

More specifically in the US, Sandoz claims biosimilars have been hampered by interchangeability regulatory guidelines and a lack of alignment across stakeholder groups for educational materials causing confusion amongst patients and healthcare professionals. The latter also impacted Canada and Brazil.

Education 52

Education Patients Healthcare Healthcare 52

Clarivate

DECEMBER 14, 2023

Pharmaceutical benefit managers, M&A activity among integrated delivery networks, disruption by nontraditional healthcare entities, enrollment, and the 2024 presidential election are five areas to pay attention to moving into 2024. Clarivate experts explain why these topics are ones to watch in 2024.

Marketing 52

Marketing Healthcare Healthcare Insurance 52